About the Authors
- Anita K. Gandhi
-
* E-mail: agandhi@celgene.com
Affiliation Department of Translational Development, Celgene Corporation, Summit, New Jersey, United States of America
- Tao Shi
-
Affiliation Department of Scientific Information Systems, Celgene Corporation, San Diego, California, United States of America
- Mingyu Li
-
Affiliation Department of Biostatistics and Programming, Celgene Corporation, Summit, New Jersey, United States of America
- Ulf Jungnelius
-
Affiliation Clinical Research and Development, Celgene, Summit, New Jersey, United States of America
- Alfredo Romano
-
Affiliation Clinical Research and Development, Celgene, Summit, New Jersey, United States of America
- Josep Tabernero
-
Affiliation Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain
- Salvatore Siena
-
Affiliation Ospedale Niguarda Ca' Granda, Milan, Italy
- Peter H. Schafer
-
Affiliation Department of Translational Development, Celgene Corporation, Summit, New Jersey, United States of America
- Rajesh Chopra
-
Affiliation Department of Translational Development, Celgene Corporation, Summit, New Jersey, United States of America
Competing Interests
Anita Gandhi, Tao Shi, Mingyu Li, Ulf Jungnelius, Alfredo Romano, Peter Schafer, and Rajesh Chopra are employees of Celgene Corporation, whose company funded this study. Salvatore Siena is a member of advisory boards for Sanofi-Aventis, AstraZeneca, Roche, Genentech, Celgene, Genomic Health, Bayer, and Amgen. Josep Tabernero has participated in advisory boards for Amgen, Celgene, Genentech, Merck-Serono, Novartis, Roche, Sanofi- Aventis, and Symphogen. Lenalidomide (Revlimid®) is a marketed Celgene product. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: UJ AR JT SS. Analyzed the data: AKG TS ML. Wrote the paper: AKG RC. Trial design and conduct: UJ AR JT SS. Intellectual input and data analysis support: PS.